Organon & Co | OGN - النقدية وما يعادلها





النقدية وما يعادلها تغيير تاريخ
Bristol-Myers Squibb USD 9.57B 852M 2026-09
Celltrion KRW 51.7B 5.1B 2026-06
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 55.69M 54.86M 2026-09
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Gilead Sciences USD 3.18B 4.45B 2026-06
Glaxosmithkline GBP 2.93B 508M 2026-09
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Merck USD 9.55B 2.7B 2026-09
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
Novartis USD 8.87B 1.99B 2026-09
Organigram Holdings CAD 10.85M 6.56M 2026-06
Organon & Co USD 1.46B 323M 2026-09
Pharma Mar EUR 19.34M 29.53M 2026-06
Qiagen NV USD 768.5M 122.21M 2026-06
Sartorius EUR 230.7M 60.3M 2026-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 3.85B 727.54M 2026-03